Skip to content
MRK Merck & Co Inc NYSE
131.75 USD 4.96% +6.23
OPEN 132.87
PREV CLOSE 125.52
DAY RANGE 133.10 - 130.11
VOLUME 16M
AVG. VOLUME 13.4M
52 WEEK RANGE 133.10 - 99.14
Interactive Brokers Logotype

Buy MRK stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 333.7B
Enterprise value 347.1B
Trailing pe 941.0714
Forward pe 13.485158
Peg ratio 13.485158
Price to sales ttm 5.5506167
Price to book mrq 8.875042
Enterprise to revenue 5.774
Enterprise to ebitda 41.838

Financials

Fiscal year ends 2023-12-31
Most recent quarter 2023-12-31
Profit margin 0.00607
Operating margin 0.00082
Return on assets ttm 0.02644
Return on equity ttm 0.00901
Income statement
Revenue ttm 60.1B
Revenue per share ttm 23.695
Quarterly revenue growth 0.058
Gross profit ttm 44B
Ebitda 7.5B
Net income to common ttm 365M
Diluted eps ttm 0.14
Quarterly earnings growth yoy 0.057845263919017
Balance sheet
Total cash mrq 7.1B
Total cash per share mrq 2.801
Total debt mrq 36.3B
Total debt to equity mrq 96.368
Current ratio mrq 1.252
Book value per share mrq 14.845
Cash flow
Operating cash flow ttm 13B
Levered free cash flow ttm 2.1B

Stock statistics

Shares outstanding 2.5B
Float shares 2.5B
Avg 10 volume 13.4M
Avg 90 volume 9.5M
Shares short 16.6M
Short ratio 2.3
Short percent of shares outstanding 0.0066000004
Percent held by insiders 0.0007
Percent held by institutions 0.78607005

Stock price summary

Fifty two week low 99.14
Fifty two week high 133.1
Fifty two week change 19.605
Beta 0.384
Day 50 ma 124.0214
Day 200 ma 111.30125

Dividends and splits

Forward annual dividend rate 3.08
Forward annual dividend yield 0.023372287145242
Trailing annual dividend rate 3
Trailing annual dividend yield 0.022765214751859
5 year average dividend yield 2.9
Payout ratio 21.1429
Dividend date 2024-04-05
Ex dividend date 2024-03-14
Last split factor 1048-for-1000 split
Last split date 2021-06-03

Merck & Co (MRK) company profile

Merck & Co Inc.(NYSE: MRK) is a healthcare company providing health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company operates through the segments of Pharmaceutical and Animal Health segments. Merck & Co also has external partnerships for the development and supply of specific health solutions.